Neurodegenerative disorders like Parkinson ' s, Alzheimer ' s, and Huntington ' s diseases generally begin late in life and are characterized by a presymptomatic phase. Therefore, biomarkers are needed for early, accurate and specifi c diagnosis and to provide surrogate endpoints for new drug effi c
Epigenetics and Biomarkers in the Staging of Neuropsychiatric Disorders
β Scribed by Trevor Archer; Richard J. Beninger; Tomas Palomo; Richard M. Kostrzewa
- Book ID
- 107678118
- Publisher
- Springer-Verlag
- Year
- 2010
- Tongue
- English
- Weight
- 400 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1029-8428
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective There is increasing interest in homocysteine as a risk factor for neuropsychiatric disorders such as stroke, dementia, depression and Parkinson's disease. This article reviews the current literature on the relationship between homocysteine and these disorders to ascertain
Changes of language and speech in neuropsychiatric patients are described by use of a quantifying procedure. In the transcript of a standardized interview the following variables are evaluated (by estimation of indices): rate of speech, pauses, indistinct and incomprehensible articulations, aphasic
## Abstract In recent years, the neurochemical analysis of neuronal proteins in cerebrospinal fluid (CSF) has become increasingly accepted for the diagnosis of neurodegenerative dementia diseases such as Alzheimer's disease and CreutzfeldtβJakob disease. CSF surrounds the central nervous system, an